Download FREE Report Sample
Download Free sampleErythropoietin is produced by interstitial fibroblasts in the kidney in close association with the peritubular capillary and proximal convoluted tubule.
Erythropoietin Drugs Market contains market size and forecasts of Erythropoietin Drugs in global, including the following market information:
Global Erythropoietin Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Erythropoietin Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Erythropoietin Drugs companies in 2021 (%)
The global Erythropoietin Drugs market was valued at 9422.9 million in 2021 and is projected to reach US$ 13650 million by 2028, at a CAGR of 5.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Epoetin-alfa Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Erythropoietin Drugs include Amgen, Johnson & Johnson, Roche, Galenica, Emcure, Kyowa Hakko Kirin, 3SBio, Biocon and LG Life Sciences. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Erythropoietin Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Erythropoietin Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Erythropoietin Drugs Market Segment Percentages, by Type, 2021 (%)
Epoetin-alfa
Darbepoetin-alfa
Epoetin-beta
Others
Global Erythropoietin Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Erythropoietin Drugs Market Segment Percentages, by Application, 2021 (%)
Anemia
Kidney Disorders
Other
Global Erythropoietin Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Erythropoietin Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Erythropoietin Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Erythropoietin Drugs revenues share in global market, 2021 (%)
Key companies Erythropoietin Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Erythropoietin Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy